RxDoctor Payments Data

Robert Bonomo

Infectious Disease · Cleveland, OHNPI 1255496592

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $5,325 of the $5,336 with a category attached, or 99.8%. Paratek Pharmaceuticals, Inc. accounts for 64.7% of it on its own, with 1 other manufacturer making up the rest.

$5,336in general payments, 2019–2025

Across 3 payments — averaging $1778.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Paratek Pharmaceuticals, Inc.$3K
  • Merck$2K
$1,021,833in research payments, 2019–2025

Across 18 payments — averaging $56,769 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merck$824K
  • Shionogi Inc$102K
  • F. Hoffmann-la Roche AG$95K

What the payments were for

  • Consulting fees$5,325100%
  • Education$110%

General payments by program year

20
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Paratek Pharmaceuticals, Inc.1$3,450
Merck2$1,886

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,336 in reported general payments places this provider in the 85th percentile of 308 infectious disease providers in Ohio.

See all infectious disease providers in Ohio →

Other infectious disease in Cleveland

See the full list for Ohio →

Where these figures come from

Is this you, or does something look wrong? →